Marketing-authorisation holder · United States
I3 Pharms
2 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| RIFABUTIN150mg · Capsule | Rifabutin | United States | Marketed | 2014 |
| ZAROXOLYN10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Metolazone | United States | Not marketed | 1973 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 2 | 2 | 0 | CompaniesAll medicines |
Top substances
The active substances in most of its medicines.